MBL2 and infectious disease: We generated an LV-based vaccine vector encoding MBL or SPD carriers, potentially usable for an infectious disease controllable by CD4+ T cells, using the EsxA, EspC (ESX-1 secretion-associated protein C), EsxH, PE19, hypoxic response protein 1 (Hrp1), and resuscitation promoting factor D (RpfD) immunogens from Mtb16,17 (Table S1).